Cargando…
Severe refractory asthma: current treatment options and ongoing research
Patients with severe asthma have a greater risk of asthma-related symptoms, morbidities, and exacerbations. Moreover, healthcare costs of patients with severe refractory asthma are at least 80% higher than those with stable asthma, mainly because of a higher use of healthcare resources and chronic s...
Autores principales: | Menzella, Francesco, Bertolini, Francesca, Biava, Mirella, Galeone, Carla, Scelfo, Chiara, Caminati, Marco |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioExcel Publishing Ltd
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6284776/ https://www.ncbi.nlm.nih.gov/pubmed/30534175 http://dx.doi.org/10.7573/dic.212561 |
Ejemplares similares
-
Precision Medicine in Targeted Therapies for Severe Asthma: Is There Any Place for “Omics” Technology?
por: Galeone, Carla, et al.
Publicado: (2018) -
Innovative treatments for severe refractory asthma: how to choose the right option for the right patient?
por: Menzella, Francesco, et al.
Publicado: (2017) -
Towards precision medicine: The application of omics technologies in asthma management
por: Scelfo, Chiara, et al.
Publicado: (2018) -
Immunological Aspects Related to Viral Infections in Severe Asthma and the Role of Omalizumab
por: Menzella, Francesco, et al.
Publicado: (2021) -
COVID-19: general overview, pharmacological options and ventilatory support strategies
por: Menzella, Francesco, et al.
Publicado: (2020)